Cardiology (all articles)
Review | Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease
12 May, 2023 | 13:24h | UTCSee all articles in the series here
Review | Treatment of amyloidosis: present and future
12 May, 2023 | 13:22h | UTCTreatment of amyloidosis: present and future – European Heart Journal Supplements
See all articles in the series here
Review | Takotsubo syndrome: more frequent in women, more dangerous in men
12 May, 2023 | 13:21h | UTCSee all articles in the series here
Review | Dilemmas in cardiology: when to recanalize a chronic total occlusion
12 May, 2023 | 13:19h | UTCSee all articles in the series here
Cohort Study | Adverse outcomes and rehospitalization more common for young women after acute myocardial infarction
11 May, 2023 | 12:18h | UTCSex Difference in Outcomes of Acute Myocardial Infarction in Young Patients – Journal of the American College of Cardiology (link to abstract – $ for full-text)
News Releases:
Commentaries:
Rehospitalizations After Acute MI: Young Women Outpace Young Men – TCTMD
Commentary on Twitter
Young women with #AMI face higher risk for repeat hospitalization after discharge compared to men. https://t.co/QC9NjCflnU#JACC #cvAMI #VIRGO #WomensHealth @MitsuakiSawano @hmkyale pic.twitter.com/iHorGCDoDF
— JACC Journals (@JACCJournals) May 6, 2023
Blood pressure variability in clinical practice: past, present and the future
11 May, 2023 | 12:13h | UTC
Aspirin for primary prevention of cardiovascular disease: what do the current USPSTF guidelines say?
11 May, 2023 | 12:11h | UTCOriginal Guideline: USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.
Related Randomized Trials:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Related Meta-Analysis:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Related Opinions:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
#347 USPSTF Update: Aspirin for Primary Prevention of CVD – The Curbsiders
RCT | High-dose statin loading prior to CABG shows no benefit in major cardiac and cerebrovascular events
11 May, 2023 | 12:10h | UTCStatin loading before coronary artery bypass grafting: a randomized trial – European Heart Journal (link to abstract – $ for full-text)
Commentary: Statin Loading No Help Before Bypass Surgery: StaRT-CABG – TCTMD
Commentary on Twitter
Statin loading before coronary artery bypass grafting: a randomised trial https://t.co/br15X5lf7k @escardio #EHJ #ESCYoung @rladeiraslopes @ehj_ed pic.twitter.com/aQFlsJfaed
— European Society of Cardiology Journals (@ESC_Journals) May 8, 2023
M-A | Intensive blood pressure control for patients aged over 60
11 May, 2023 | 12:07h | UTC
M-A | Fruit and vegetable consumption and the risk of hypertension
11 May, 2023 | 12:02h | UTC
Atrial fibrillation incidence associated with exposure to anticancer drugs used as monotherapy in clinical trials
10 May, 2023 | 15:54h | UTCEditorials:
Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think – JACC: CardioOncology
Commentary on Twitter
Annual incidence rate of #AFib assoc w/ anticancer drugs were ⬆️ in pts w/ hematologic malig. It was found for #ibrutinib 4.92 (95% CI: 2.91-8.31), #clofarabine 2.38 (95% CI: 0.66-8.55), & #ponatinib 2.35 (95% CI: 1.78-3.12) per 100 person-yrs https://t.co/W2RGMrE37F… pic.twitter.com/NnbmUVcci5
— JACC Journals (@JACCJournals) April 27, 2023
Consensus Paper | Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
10 May, 2023 | 15:51h | UTC
Management of patients with heart failure and preserved ejection fraction
10 May, 2023 | 15:49h | UTCManagement of patients with heart failure and preserved ejection fraction – Heart
Related: 2023 ACC expert consensus on management of heart failure with preserved ejection fraction
Commentary on Twitter
Education in Heart: Management of patients with HFpEF https://t.co/SA7d0WH891 pic.twitter.com/59BK9OgYNe
— Heart_BMJ (@Heart_BMJ) April 29, 2023
Formal consensus study on surgery to replace the aortic valve in adults aged 18–60 years
10 May, 2023 | 15:38h | UTCFormal consensus study on surgery to replace the aortic valve in adults aged 18–60 years – Heart
Commentary on Twitter
Formal consensus study on surgery to replace the aortic valve in adults aged 18–60 years https://t.co/69qlooAuhp pic.twitter.com/6hVWMElYqq
— Heart_BMJ (@Heart_BMJ) April 23, 2023
M-A | PCI vs. CABG in non–ST-elevation coronary syndromes and multivessel disease
10 May, 2023 | 15:35h | UTC
Guideline | Management of type B aortic dissection
10 May, 2023 | 15:32h | UTC
Review | Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis
9 May, 2023 | 14:19h | UTCSee all articles in the series here
Review | Causes of sudden death
9 May, 2023 | 14:16h | UTCCauses of sudden death – European Heart Journal Supplements
See all articles in the series here
Review | DOACs and rheumatic valvulopathy: always a red light?
9 May, 2023 | 14:15h | UTCDOACs and rheumatic valvulopathy: always a red light? – European Heart Journal Supplements
See all articles in the series here
New CV POCUS workbook addresses current value and vision for future use
8 May, 2023 | 13:10h | UTC
RCT | Ibrutinib plus rituximab improve CLL PFS vs chemoimmunotherapy, but increased unexplained/cardiac deaths
8 May, 2023 | 13:00h | UTC
Cohort Study | Ibrutinib is associated with increased cardiovascular events and major bleeding in older CLL patients
8 May, 2023 | 12:59h | UTC
Commentary on Twitter
#Ibrutinib was associated with an increased risk of stroke, #AFib and bleeding, especially in older patients. The risk of major bleeding is higher than previously reported. https://t.co/dhP7Kwogdt#JACCCardioOnc #CardioOnc #geriheme #lymsm #leusm #CLL @AkivaDiamond @paolocaimiMD pic.twitter.com/MvzCh1i6LU
— JACC Journals (@JACCJournals) May 4, 2023
Review | The bidirectional association between atrial fibrillation and myocardial infarction
8 May, 2023 | 12:54h | UTCThe bidirectional association between atrial fibrillation and myocardial infarction – Nature Reviews Cardiology (if the link is paywalled, try this one)
Commentary on Twitter
In our latest Review, @JKornej, @EmeliaBenjamin et al. explore the bidirectional association between #AtrialFibrillation and myocardial infarction: https://t.co/K3iH24e57U pic.twitter.com/sKBrhRJXf3
— Nature Reviews Cardiology (@NatRevCardiol) April 17, 2023
Cohort Study | Long-term beta-blocker use in MI patients without heart failure or LVSD not linked to better cardiovascular outcomes
5 May, 2023 | 15:29h | UTCEditorial: Should beta-blockers be recommended after myocardial infarction when left ventricular ejection fraction is normal? – Heart (free for a limited period)
News Release: Study questions long term beta blocker use for heart attack patients – BMJ Newsroom
Related Systematic Review: Beta‐blockers in patients without heart failure after myocardial infarction – Cochrane Library.
Expert Panel | Appropriate use criteria for the management of aortic stenosis
5 May, 2023 | 15:22h | UTC